ROSEN, A LEADING NATIONAL FIRM, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important January 12 Deadline in Securities Class Action – PRMB, PRMW GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water […]

(NASDAQ:SLNO), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or directors have

(CNSX:AYR.A),(CNSX:AYR.A.CN),(OTC US:AYRWF),(Other OTC:AYRWF),(CNSX:AYR-A.CN),(CNSX:AYR-A), MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that Donna Granato, the Company's interim Chief Financial Officer (“CFO”), will depart AYR December 31, 2025. AYR Interim CEO Blake Holzgrafe said, “As we continue

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. – SLNO GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such investors are advised to contact Danielle

AYR Wellness Announces Leadership Update GlobeNewswire December 30, 2025 MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that Donna Granato, the Company's interim Chief Financial Officer (“CFO”), will depart AYR December 31, 2025. AYR Interim CEO

(TSX-V:STUD),(Boerse Frankfurt – Freiverkehr:HM40.F),(OTC US:STLNF),(Other OTC:STLNF),(Frankfurt:FE0),(Boerse Frankfurt – Freiverkehr:B76), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce that, further to its

Stallion Uranium Announces Increase to Flow-Through Financing and Completes Private Placement GlobeNewswire December 30, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased

LexShares, Inc., a New York City-based litigation finance firm, and Cayse Llorens, a private investor and LexShares' former CEO, announce lawsuit resolution. https://mma.prnewswire.com/media/2852406/LexShares_Logo.jpg LexShares thanks Mr. Llorens for the contributions he made during his time at LexShares.Similarly, Mr. Llorens appreciates the opportunities and collaboration provided to him while atLexShares. Mr.Llorens remains vested in LexShares' ongoing

(NYSE:AGL), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. – AGL GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle